Washington Trust’s Takeda Pharmaceutical TAK Stock Holding History

Washington Trust’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-407	Closed	-$7K	–	1081
2021 Q3	$7K	Hold	407	–	–	﹤0.01%	825
2021 Q2	$7K	Hold	407	–	–	﹤0.01%	830
2021 Q1	$8K	Hold	407	–	–	﹤0.01%	780
2020 Q4	$8K	Hold	407	–	–	﹤0.01%	768
2020 Q3	$8K	Buy	407 +35	+9%	+$637	﹤0.01%	757
2020 Q2	$7K	Hold	372	–	–	﹤0.01%	684
2020 Q1	$6K	Buy	+372	New	+$6.74K	﹤0.01%	741

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BCP

BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Washington Trust's TAK Position: Q4 2021 in Review

Washington Trust sold out of Takeda Pharmaceutical (TAK) in Q4 2021, closing a stake of 407 shares — an estimated $7K sold.

Washington Trust first reported a position in TAK in Q1 2020 and held it in 7 quarters. The position peaked at $8K in Q1 2021. 298 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

Washington Trust reported no remaining Takeda Pharmaceutical position as of Q4 2021 after selling out during the quarter.
Washington Trust sold 407 Takeda Pharmaceutical shares in Q4 2021, an estimated $7K.
Washington Trust first reported a position in Takeda Pharmaceutical in Q1 2020 and held it in 7 quarters.
Washington Trust's Takeda Pharmaceutical position peaked at $8K in Q1 2021.
298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on Washington Trust's 13F filing for Q4 2021, filed 9 Feb 2022.